Standard BioTools
LAB
LAB
100 hedge funds and large institutions have $941M invested in Standard BioTools in 2013 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 37 increasing their positions, 32 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
16% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 32
12% more funds holding
Funds holding: 89 → 100 (+11)
Holders
100
Holding in Top 10
2
Calls
$10.1M
Puts
$7.66M
Top Buyers
| 1 | +$28.6M | |
| 2 | +$21.2M | |
| 3 | +$18.4M | |
| 4 |
SCM
Sandler Capital Management
New York
|
+$13.2M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.5M |
Top Sellers
| 1 | -$26M | |
| 2 | -$10.9M | |
| 3 | -$8.61M | |
| 4 |
JP Morgan Chase
New York
|
-$8.27M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$7.12M |